Tech Company Financing Transactions
QuantX Biosciences Funding Round
LAV Fund, Sanofi Ventures and HongShan participated in a $85 million Series B funding round for QuantX Biosciences. The round closed on 2/9/2026.
Transaction Overview
Company Name
Announced On
2/9/2026
Transaction Type
Venture Equity
Amount
$85,000,000
Round
Series B
Investors
Proceeds Purpose
The proceeds from this financing will be used to support the clinical development of its best-in-class STAT6 oral small molecule inhibitor and IL-17 oral small molecule inhibitor, in addition to continued discovery efforts for oral therapies in immunology and inflammation.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
103 Carnegie Center 309
Princeton, NJ 08540
USA
Princeton, NJ 08540
USA
Phone
Undisclosed
Website
Email Address
Overview
At QuantX, we leverage the power of computation and modeling to accelerate the discovery of superior medicines for validated targets in immunology and inflammation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Wei Li
Browse more venture capital transactions:
Prev: 2/9/2026: Qontext venture capital transaction
Next: 2/9/2026: Zoth venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs